Cargando…

Use of a point-of-care test to rapidly assess levels of SARS-CoV-2 nasal neutralising antibodies in vaccinees and breakthrough infected individuals

Despite SARS-CoV-2 vaccines eliciting systemic neutralising antibodies (nAbs), breakthrough infections still regularly occur. Infection helps to generate mucosal immunity, possibly reducing disease transmission. Monitoring mucosal nAbs is predominantly restricted to lab-based assays, which have limi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tan, Chee Wah, Lim, Chuan Kok, Prestedge, Jacqueline, Batty, Mitchell, Mah, Yun Yan, O’Han, Michelle, Wang, Lin-Fa, Kilby, Dean, Anderson, Danielle E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10662396/ https://www.ncbi.nlm.nih.gov/pubmed/37985674 http://dx.doi.org/10.1038/s41598-023-47613-8

Ejemplares similares

Potent cross-reactive antibodies following Omicron breakthrough in vaccinees
por: Nutalai, Rungtiwa, et al.
Publicado: (2022)

SARS-CoV-2 breakthrough infection in vaccinees induces virus-specific nasal-resident CD8(+) and CD4(+) T cells of broad specificity
por: Lim, Joey Ming Er, et al.
Publicado: (2022)

Regular and booster vaccination with inactivated vaccines enhance the neutralizing activity against Omicron variant both in the breakthrough infections and vaccinees
por: YangYang, et al.
Publicado: (2022)

Omicron variants breakthrough infection elicited higher specific memory immunity than third dose booster in healthy vaccinees
por: Yu, Pei, et al.
Publicado: (2023)

Elevated neutralization of Omicron with sera of COVID-19 recovered and breakthrough cases vaccinated with Covaxin than two dose naïve vaccinees
por: Yadav, Pragya D., et al.
Publicado: (2022)

Assessment of the Biological Impact of SARS-CoV-2 Genetic Variation Using an Authentic Virus Neutralisation Assay with Convalescent Plasma, Vaccinee Sera, and Standard Reagents
por: Coombes, Naomi S., et al.
Publicado: (2023)

Low neutralisation of the omicron BA.2 sublineage in boosted individuals who had breakthrough infections
por: Karaba, Andrew H, et al.
Publicado: (2022)

Omicron BQ.1 and BQ.1.1 escape neutralisation by omicron subvariant breakthrough infection
por: Jiang, Xiao-Lin, et al.
Publicado: (2023)

Poststudy Point-of-Care Oral Fluid Testing in Human Immunodeficiency Virus-1 Vaccinees
por: Oganezova, Karina, et al.
Publicado: (2020)

Comparison of Four T-cell Assays and Two Binding Antibody Assays in SARS-CoV-2 Vaccinees With or Without Omicron Breakthrough Infection
por: Seo, Yeon Ju, et al.
Publicado: (2023)

Adventitious viral genomes in vaccines but not in vaccinees.
por: Weiss, R A
Publicado: (2001)

Comparative neutralisation profile of SARS-CoV-2 omicron subvariants BA.2.75 and BA.5
por: Tan, Chee-Wah, et al.
Publicado: (2022)

A LABORATORY VALIDATION OF SELF-COLLECTED NASAL SWAB AND RHINOSWAB FOR THE DETECTION OF SARS-COV-2
por: Batty, M., et al.
Publicado: (2023)

Neutralising activity and antibody titre in 10 patients with breakthrough infections of the SARS-CoV-2 Omicron variant in Japan
por: Okumura, Nobumasa, et al.
Publicado: (2022)

Neutralisation and the brickwall
por: Hereward, H G
Publicado: (1974)

Virus Neutralisation: New Insights from Kinetic Neutralisation Curves
por: Magnus, Carsten
Publicado: (2013)

Neutralizing Antibody Response of Vaccinees to SARS-CoV-2 Variants
por: Anichini, Gabriele, et al.
Publicado: (2021)

Impact of influenza vaccination in the Netherlands, 2007–2016: Vaccinees consult their general practitioner for clinically diagnosed influenza, acute respiratory infections, and pneumonia more often than non-vaccinees
por: Caini, Saverio, et al.
Publicado: (2021)

A point-of-care lateral flow assay for neutralising antibodies against SARS-CoV-2
por: Fulford, Thomas S., et al.
Publicado: (2021)

Previously infected vaccinees broadly neutralize SARS-CoV-2 variants
por: Leier, Hans C., et al.
Publicado: (2021)

Neutralisation pockets and spectral lines
por: Gröbner, Oswald
Publicado: (1972)

On Toxic Neutralisations: II. Reconstitution
por: Richardson, Benjamin Ward
Publicado: (1894)

Mechanisms of Rhinovirus Neutralisation by Antibodies
por: Touabi, Lila, et al.
Publicado: (2021)

Les taux de personnes vaccinées et non vaccinées contre le COVID-19 en France. Comparaison des indicateurs en open data et tentative d'estimation
por: Geay, C., et al.
Publicado: (2023)

Omicron BA.2.75 variant is efficiently neutralised following BA.1 and BA.5 breakthrough infection in vaccinated individuals, Israel, June to September 2022
por: Atari, Nofar, et al.
Publicado: (2022)

Dynamics of SARS-CoV-2 neutralising antibody responses and duration of immunity: a longitudinal study
por: Chia, Wan Ni, et al.
Publicado: (2021)

Ability of History Taking Alone to Identify Early Pregnancies Among Potential Measles Vaccinees
por: Mead, Philip B.
Publicado: (1994)

Identification of Novel Yellow Fever Class II Epitopes in YF-17D Vaccinees
por: Mateus, Jose, et al.
Publicado: (2020)

Estimating the proportion of vaccine-induced hospitalized dengue cases among Dengvaxia vaccinees in the Philippines
por: Flasche, Stefan, et al.
Publicado: (2019)

Natural SARS-CoV-2 Infection Affects Neutralizing Activity in Saliva of Vaccinees
por: Garziano, Micaela, et al.
Publicado: (2022)

Interactions between Severe Allergy and Anxiety in Anti-SARS-CoV-2 Vaccinees
por: Asperti, Chiara, et al.
Publicado: (2022)

Waning of Antibody Response Among Vaccinees who Received Two Doses of Covishield Vaccine
por: Haritay, Shivani, et al.
Publicado: (2023)

Inflection Point: Ideas for Accelerating Breakthroughs and Improving Cardiovascular Health
por: Krumholz, Harlan M.
Publicado: (2020)

Beyond Change Management: How to Achieve Breakthrough Results Through Conscious Change Leadership
por: Anderson, Dean
Publicado: (2010)

Serological Cross Reactivity between Zika and Dengue Viruses in Experimentally Infected Monkeys
por: Mani, Shailendra, et al.
Publicado: (2018)

Neutralising Antibodies against Ricin Toxin
por: Prigent, Julie, et al.
Publicado: (2011)

Electron cooling with neutralised electron beams
por: Bosser, Jacques, et al.
Publicado: (1994)

Electron cooling with neutralised electron beams
por: Bosser, J, et al.
Publicado: (1994)

On Toxic Neutralisations: I.—Isomeric Variation
por: Richardson, Benjamin Ward
Publicado: (1894)

Immunogenicity of COVID-19 vaccines and levels of SARS-CoV-2 neutralising antibody in the Bruneian population: Protocol for a national longitudinal study
por: Ghani, Hazim, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_lgfs98u5us1ka316vi3pegcitr